Christopher S. Henney has been appointed chairman of the board of Anthera Pharmaceuticals Inc. (San Mateo, CA).
Christopher S. Henney has been appointed chairman of the board of Anthera Pharmaceuticals Inc. (San Mateo, CA). Henney has served as an independent director of Anthera since 2006. He is a co-founder of three major publicly held US biotechnology companies: Immunex‚ ICOS, and Dendreon‚ and has been associated with the formation of several others. Most recently Henney has served as chairman and CEO of Dendreon, and as chairman of SGX Pharmaceuticals and of Oncothyreon.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics
February 5th 2025Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.